Clinical Trials · NCT00598312
Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Oakwood Laboratories, LLC
- Enrollment
- 201
- Start date
- Apr 2007
- Locations
- 1 site, United States
- Primary endpoint
- The percentage of responders who attain and maintain castrate levels of serum testosterone